Medical Device Recall Procedures in the UAE: A Legal Guide
How UAE law and health authority policies govern medical device recalls, from risk classification and reporting to investigation, execution and compliance.
A guide to medical device recall procedures in the UAE: the legal framework, DOH recall classes, reporting duties and how suppliers must carry out a recall.
Reviewed by Mohamed Noureldin, Founder, Managing Partner & Senior Legal Consultant
Related Services: Explore our medical malpractice disputes services for practical legal support in this area.
Introduction
The United Arab Emirates (UAE) has built a robust regulatory environment for the healthcare sector, with a particular emphasis on the safety and efficacy of medical devices. A critical part of this system is the medical device recall UAE process that authorities mandate when a product is found to be non-compliant or defective, or poses a risk to public health.
This system is not merely procedural. It is designed to rigorously test and confirm the safety of every medical product on the market. For manufacturers, distributors and healthcare providers, compliance requires a clear understanding of their legal obligations and careful use of resources to manage risk.
The UAE's recall rules draw on federal laws, ministerial decrees and specific policies from health authorities such as the Department of Health (DOH) and the Ministry of Health and Prevention (MOHAP). This article explains the legal and regulatory mechanics of medical device recalls in the UAE and offers practical guidance for everyone in the medical device supply chain.
Legal Framework for Medical Device Recalls in the UAE
The legal framework governing medical device recall UAE procedures has several layers. It draws its authority from federal laws and from the regulations that health authorities enforce.
Federal Law No. 10 of 2018 on Product Safety
At the federal level, the primary legislation is Federal Law No. 10 of 2018 on Product Safety. It sets the basic principles for ensuring that all products placed on the UAE market, including medical devices, are safe for consumers. The law defines an unsafe product and sets out suppliers' obligations to prevent its distribution.
The law provides the legal basis for regulatory action such as product withdrawal and recall, and non-compliance is met with significant penalties. It empowers the Ministry of Economy and the Emirates Authority for Standardization and Metrology (ESMA) to oversee product safety. For medical devices, however, the primary regulators are the Ministry of Health and Prevention (MOHAP) and local health authorities such as the Department of Health (DOH) in Abu Dhabi and the Dubai Health Authority (DHA).
The Executive Regulations: Cabinet Resolution No. (5) of 2020
The Cabinet Resolution No. (5) of 2020 Concerning the Executive Regulations of Federal Law No. (10) of 2018 on Product Safety sets out the detailed rules for implementing the law. It clarifies the roles of the competent authorities, defines the criteria for risk assessment and establishes procedures for market surveillance and for enforcing corrective actions, including recalls.
The resolution creates a clear, non-discretionary mandate for suppliers to cooperate fully with authorities and to bear the full cost of recall operations. Together, the federal law and its executive regulations ensure that product safety standards apply consistently across all Emirates, leaving no regulatory gaps for non-compliant operators to exploit.
The system places the burden of proof squarely on the supplier to demonstrate product safety, rather than on the regulator to prove a danger. This preventive approach is a hallmark of the UAE's modern regulatory philosophy.
Health Authority Policies
The health authorities have issued their own detailed policies and circulars that put the federal law into practice. For instance, the DOH's Policy for Quarantine and Recall of Medical Products provides a detailed roadmap for identifying, quarantining and recalling deficient medical products.
This policy sets out a classification system for recalls (Class I, II and III) based on the level of risk the device poses, so that the response matches the severity of the potential harm. It mandates a structured, time-bound process for reporting, investigation and compliance, so that any potential threat is dealt with quickly.
The broad federal mandate for product safety and the detailed health authority rules work together. The result is a comprehensive system designed to protect public health while holding every party in the supply chain accountable.
How a Medical Device Recall Works in the UAE
When authorities initiate a medical device recall UAE procedure, it follows a highly structured process designed for swift and effective action. Manufacturers, suppliers and healthcare facilities must coordinate their efforts, all under the strict oversight of the relevant health authority. The procedures are designed to address any threat to patient safety with precision and accountability.
Recall Classification
The DOH policy, mirroring international standards, establishes a clear classification system for recalls, so that the response is scaled to the potential for harm. The classification dictates the urgency and scope of the recall.
| Recall Class | Definition | Urgency and Action Timeline |
|---|---|---|
| Class I (Critical) | A situation where there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death. | Immediate action required. Recall report must be completed within 1 week. |
| Class II (Major) | A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. | Prompt action required. Recall report must be completed within 3 weeks. |
| Class III (Minor) | A situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences, but violates labelling or manufacturing regulations. | Action required to prevent future occurrences. Recall report must be completed within 3 weeks. |
Reporting and Notification
Identifying a potentially deficient medical device triggers a mandatory chain of reporting. Healthcare facilities and professionals are legally obliged to report any suspected device deficiency to the DOH's Pharmacovigilance & Drugs Education (PVE) section immediately. This initial report sets an official investigation in motion.
The PVE then notifies the market authorisation holder (MAH) or supplier and gives it a set timeframe to address the quality concern and, if necessary, to quarantine the product under investigation. This ensures that the supplier is held accountable from the outset. Information is shared quickly through official circulars and direct communication instructing all licensed healthcare facilities to stop using the device concerned.
Investigation
The investigation is a critical stage of the recall process. On receiving notification of a deficient product, the DOH PVE section opens a formal inquiry. This is not a collaborative exercise. It is a rigorous examination designed to remove any doubt about the product's safety.
The investigation may involve collecting and testing samples of the device, a process designed to be independent and impartial. The authorities can compel the supplier to provide detailed manufacturing records, quality control data and distribution lists. This information is then cross-checked against reports from healthcare providers and international regulatory alerts.
The investigation follows the principle of "trust but verify", so the supplier's claims are subjected to intense scrutiny. The goal is to build an irrefutable case for action, should a recall be deemed necessary. Decisions therefore rest on objective evidence rather than on the supplier's assurances, which safeguards public health to an uncompromising standard.
Execution and Monitoring
Once a recall is formally initiated, the MAH or supplier is responsible for carrying it out. This involves physically removing the device from the market, including from all healthcare facilities, pharmacies and distribution centres. The supplier must put in place a comprehensive plan to track and account for all recalled units.
The process is not simply logistical. It is a managed operation that must be documented in detail. The supplier is required to submit a final recall report to the DOH within the specified timeline, providing evidence that the recall has been completed successfully.
The DOH actively monitors the entire process. Failure to comply with any aspect of the recall order can result in severe sanctions, including fines, licence revocation and even facility closure. This close monitoring keeps the recall process sound and ensures that public safety remains the paramount consideration.
What Medical Device Recall Rules Mean for Your Business
The strict medical device recall UAE framework has major implications for every business in the medical device sector. Reacting to a recall notice is not enough. A proactive, well-designed compliance system must be built into the organisation's day-to-day operations.
Quality Management and Recall Readiness
The potential for significant financial penalties, reputational damage and even criminal liability makes careful investment in risk management essential. Companies must invest in robust quality management systems that can identify potential device deficiencies early. This includes rigorous post-market surveillance and a clear internal protocol for escalating and investigating adverse event reports.
Because the regulatory response is tiered by recall class, a company's preparedness must be equally nuanced, with scalable plans that can be activated depending on the severity of the issue.
Managing the Costs of a Recall
The legal and operational costs of a recall can be substantial. They include the direct costs of retrieving and replacing the product, as well as the indirect costs of business interruption and loss of market confidence. To manage these financial risks, companies should consider specialised insurance products and establish contingency funds.
From a legal perspective, it is critical to have an established relationship with a law firm that has deep expertise in UAE healthcare regulation. This relationship is not just for crisis management. It can provide ongoing advice on compliance, support the development of recall preparedness plans and represent the company's interests in any contested proceedings with regulatory authorities.
Being able to show a well-designed, proactive compliance strategy can significantly influence the outcome of any regulatory investigation. It is a critical part of long-term business sustainability in the UAE's demanding healthcare market.
Building a Proactive Compliance Posture
A proactive compliance posture goes beyond internal quality control. It involves actively engaging with the regulatory landscape and anticipating potential challenges. Companies should dedicate resources to monitoring changes in UAE legislation and health authority policies, so that their internal procedures always reflect the latest requirements. This includes taking part in industry forums and keeping open lines of communication with regulatory bodies.
A truly strategic approach also means building "recall-ready" operations. In practice, this means having:
- pre-drafted communication templates for notifying customers and regulators;
- a dedicated, trained recall management team; and
- pre-qualified logistics partners who can carry out a product retrieval at a moment's notice.
The ability to mobilise these resources swiftly and efficiently can significantly reduce the operational and financial disruption of a recall. It also signals to the authorities that the company is a responsible and reliable participant in the healthcare system. In a strict regulatory environment, this level of preparedness can be a decisive factor in protecting a company's reputation and market position.
Conclusion
The regulatory framework governing medical device recall UAE procedures is a demanding and carefully designed system. Its strict requirements call for unwavering compliance from all stakeholders. It is built to address public health threats decisively, with a clear classification of risks and a mandate for swift, coordinated recall operations.
For manufacturers, suppliers and healthcare providers, a passive or reactive approach is untenable. Success in this market requires a comprehensive compliance system, robust post-market surveillance and legal preparedness for the complexities of the recall process. Understanding the tiered nature of regulatory sanctions, and the importance of a well-documented, transparent and efficient recall plan, is paramount.
Ultimately, the UAE's rigorous approach to medical device safety reflects its commitment to patient welfare and sends a clear message to the industry: only those who can demonstrate the highest standards of quality and accountability will be permitted to operate.
For further information, please explore our related services:
- Corporate & Commercial Law
- Healthcare Law
- Litigation & Dispute Resolution
- Regulatory & Compliance
- Intellectual Property
Additional Resources
Explore more of our insights on related topics: